000			01535 a2200421 4500
005			20250513153729.0
264		0	_c19981110
008			199811s 0 0 eng d
022			_a0002-8223
024	7		_a10.1016/S0002-8223(98)00266-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aNaglak, M
245	0	0	_aWhat to consider when conducting a cost-effectiveness analysis in a clinical setting. _h[electronic resource]
260			_bJournal of the American Dietetic Association _cOct 1998
300			_a1149-54 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAudiovisual Aids
650	0	4	_aCholesterol, Dietary _xadministration & dosage
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDiet
650	0	4	_aDiet Records
650	0	4	_aDiet Therapy _xeconomics
650	0	4	_aDiet, Fat-Restricted
650	0	4	_aEnergy Intake
650	0	4	_aHumans
650	0	4	_aHypercholesterolemia _xdiet therapy
650	0	4	_aPatient Compliance
650	0	4	_aPatient Education as Topic
650	0	4	_aPilot Projects
650	0	4	_aTreatment Outcome
700	1		_aMitchell, D C
700	1		_aKris-Etherton, P
700	1		_aHarkness, W
700	1		_aPearson, T A
773	0		_tJournal of the American Dietetic Association _gvol. 98 _gno. 10 _gp. 1149-54
856	4	0	_uhttps://doi.org/10.1016/S0002-8223(98)00266-1 _zAvailable from publisher's website
999			_c9752252 _d9752252